In addition, tumor-derived secretory molecules like VEGF-A contribute to the downregulation of endothelial cell adhesion molecules such as ICAM-1, thereby inhibiting T-cell adhesion to endothelial cells and subsequent infiltration in the tumor. This evidence concerns the gene ICAM1 and neoplasm.